検索結果 - Tsai, Max

Paclitaxel-loaded polymeric microparticles: Quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics 著者: Tsai, Max, Lu, Ze, Wientjes, M. Guillaume, Au, Jessie L.-S.

全文の入手 全文の入手 全文の入手

Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol 著者: Tsai, Max, Case, Michael, Ardayfio, Paul, Hochstetler, Helen, Wilbraham, Darren

全文の入手 全文の入手 全文の入手

A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor 著者: Tsai, Max, Chrones, Lambros, Xie, Jinhui, Gevorkyan, Hakop, Macek, Thomas A.

全文の入手 全文の入手 全文の入手

A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis 著者: Naik, Himanshu, Tsai, Max C., Fiedler-Kelly, Jill, Qiu, Ping, Vakilynejad, Majid

全文の入手 全文の入手 全文の入手

The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus 著者: Dudkowski, Caroline, Tsai, Max, Liu, Jie, Zhao, Zhen, Schmidt, Eric, Xie, Jeannie

全文の入手 全文の入手 全文の入手

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor‐Positive Allosteric Modulator (D1PAM), in Healthy Subjects 著者: Wilbraham, Darren, Biglan, Kevin M., Svensson, Kjell A., Tsai, Max, Kielbasa, William

全文の入手 全文の入手 全文の入手

TUMOR PENETRATING MICROPARTICLES FOR INTRAPERITONEAL THERAPY OF OVARIAN CANCER 著者: Lu, Ze, Tsai, Max, Lu, Dan, Wang, Jie, Wientjes, M. Guillaume, Au, Jessie L.-S.

全文の入手 全文の入手 全文の入手

Single-dose pharmacokinetics and safety of azilsartan medoxomil in children and adolescents with hypertension as compared to healthy adults 著者: Webb, Nicholas J. A., Wells, Thomas, Tsai, Max, Zhao, Zhen, Juhasz, Attila, Dudkowski, Caroline

全文の入手 全文の入手 全文の入手

EFFECTS OF CARRIER ON DISPOSITION AND ANTITUMOR ACTIVITY OF INTRAPERITONEAL PACLITAXEL 著者: Tsai, Max, Lu, Ze, Wang, Jie, Yeh, Teng-Kuang, Wientjes, M. Guillaume, Au, Jessie L.-S.

全文の入手 全文の入手 全文の入手

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease 著者: Wilbraham, Darren, Biglan, Kevin M., Svensson, Kjell A., Tsai, Max, Pugh, Melissa, Ardayfio, Paul, Kielbasa, William

全文の入手 全文の入手 全文の入手

Multiscale Tumor Spatiokinetic Model for Intraperitoneal Therapy 著者: Au, Jessie L.-S., Guo, Peng, Gao, Yue, Lu, Ze, Wientjes, Michael G., Tsai, Max, Wientjes, M. Guillaume

全文の入手 全文の入手 全文の入手

Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study 著者: Wilbraham, Darren, Berg, Paul H., Tsai, Max, Liffick, Emily, Loo, Li Shen, Doty, Erin Gautier, Sellers, Edward

全文の入手 全文の入手 全文の入手

A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationsh... 著者: Goldsmith, Paul, Affinito, John, McCue, Maggie, Tsai, Max, Roepcke, Stefan, Xie, Jinhui, Gertsik, Lev, Macek, Thomas A.

全文の入手 全文の入手 全文の入手

Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls 著者: Pearlman, Eric M., Wilbraham, Darren, Dennehy, Ellen B., Berg, Paul H., Tsai, Max, Doty, Erin G., Kay, Gary G.

全文の入手 全文の入手 全文の入手

Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine 著者: Tsai, Max, Nery, Emel Serap Monkul, Kerr, Lisa, Khanna, Rashna, Komori, Mika, Dennehy, Ellen B., Wilbraham, Darren, Winner, Paul

全文の入手 全文の入手 全文の入手

An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients 著者: Gilleen, James, Farah, Yakub, Davison, Cate, Kerins, Sarah, Valdearenas, Lorena, Uz, Tolga, Lahu, Gez, Tsai, Max, Ogrinc, Frank, Reichenberg, Avi, Williams, Steve C., Mehta, Mitul A., Shergill, Sukhi S.

全文の入手 全文の入手 全文の入手